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CM2 is an integral membrane protein encoded by the inﬂuenza C virus M gene. To examine the effects of
the cytoplasmic tail of CM2 on its biochemical properties, deletion and substitution mutations were
introduced into CM2 cytoplasmic tail at residues 47–115, and the expressed CM2 mutants were in-
vestigated. Although the cytoplasmic tail is not essential for the oligomerization of CM2, it may affect the
degree of oligomerization. The residues 47–48, 67–69, 73–90 and 113–115 were all required for the
proper expression of CM2. Pulse-chase experiments suggest that residues 47–48, 67–69, 73–75 and 79–
87 stabilize CM2, thereby affecting CM2 expression. The C-terminal region at residues 61–115 is not
essential for CM2 transport to the cell surface, and a 14-amino-acid, but not an 11-amino-acid, cyto-
plasmic tail is sufﬁcient for the cell surface expression of CM2. These results suggest that either certain
amino acid sequences or the length of the CM2 cytoplasmic tail are necessary for the proper con-
formational maturation, stability, expression level and intracellular transport of CM2.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The inﬂuenza C virus genome consists of seven single-stranded
RNA segments of negative polarity [1]. The spliced and unspliced
mRNAs from RNA segment 6 (M gene) of inﬂuenza C virus encode
the 242-amino-acid (aa) matrix (M1) protein, and a 374-aa protein,
designated P42, which contains an additional 132 amino acids
from the C-terminus of M1 [2–4]. P42 is cleaved by signal pepti-
dase at the C-terminal side of Ala259 to generate CM2, composed
of the C-terminal 115 amino acids, and M1′, composed of the
N-terminal 259 amino acids [5,6].
CM2 is an integral membrane protein that is oriented in
membranes with 23-aa N-terminal extracellular, 23-aa trans-
membrane, and 69-aa C-terminal cytoplasmic domains [7,8]. CM2
is modiﬁed post-translationally by N-glycosylation at Asn11, which
converts non-glycosylated CM20 (Mr16 kDa) into CM2a
(Mr18 kDa) [7,8]. The processing of the carbohydrate chain from
a high-mannose type to a complex type converts CM2a into CM2b
with heterogeneous electrophoretic mobility (Mr22–30 kDa) [7].
CM2 is also modiﬁed by palmitoylation at Cys65 and by phos-
phorylation at Ser78 and Ser103 [7,9,10]. Furthermore, CM2 forms
dimers and tetramers by intermolecular disulﬁde bonds at Cys1,r B.V. This is an open access article
(S. Hongo).Cys6 and Cys20 [7,8,10]. CM2 is transported to the cell surface
[7,8,10] and is also incorporated into virions [7].
The whole-cell currents of Xenopus laevis oocytes expressing
CM2 demonstrated that CM2 forms a voltage-activated ion chan-
nel permeable to chloride ions [11]. When CM2 was co-expressed
with a pH-sensitive inﬂuenza A virus hemagglutinin (HA), CM2
protected the HA against low pH-induced conformational change
in the trans-Golgi network, indicating that CM2 can elevate trans-
Golgi pH via proton permeability [12].
The M2 protein of inﬂuenza A virus possesses proton ion
channel activity, and is thought to conduct protons from the en-
dosomes into the interior of the virus to disrupt interactions be-
tween the vRNPs and M1, facilitating uncoating [1]. In addition,
M2 plays a role in infectious virion production, through facilitation
of the efﬁcient packaging of genome segments into virions, as well
as in virion morphology [1]. Inﬂuenza B virus BM2 protein also
possesses proton channel activity [13] and is involved in genome
packaging [14]. As the biochemical properties of CM2 are very
similar to those of M2 [7,8] and, like M2 and BM2, CM2 appears to
possess proton permeability [12], it is reasonable to assume that
CM2 may play a role in inﬂuenza C virus replication. Therefore, we
examined the effect of CM2 on inﬂuenza C virus replication and
demonstrated that CM2 plays a role in the packaging of the re-
porter gene into inﬂuenza C virus-like particles (VLPs) as well as in
the uncoating of the VLPs, suggesting that CM2 is essential for
virus replication [15]. The loss of sites for N-glycosylation andunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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these post-translational modiﬁcations in the extracellular domain
of CM2 are required for efﬁcient virus replication [16,17]. In con-
trast, no inhibition in growth was observed in viruses lacking a
palmitoylation site in the cytoplasmic region of CM2, suggesting
that the palmitoylation of CM2 does not affect virus replication
[18]. The cytoplasmic domains of inﬂuenza A virus M2 and inﬂu-
enza B virus BM2 play a role in virion morphology and genome
packaging [19–22]. However, except for palmitoylation, the effect
of the cytoplasmic tail of CM2 on inﬂuenza C virus replication has
not yet been investigated. In this study, we examined whether the
cytoplasmic tail of CM2 affects its biochemical properties and in-
tracellular functions prior to an analysis of the effect of the CM2
cytoplasmic tail on inﬂuenza C virus replication. To this end, de-
letion and substitution mutations were introduced into the cyto-
plasmic tail of CM2, and analyses of the expressed CM2 mutants
indicated that the cytoplasmic residues are involved in the ex-
pression level, oligomerization, stability and intracellular transport
of CM2.2. Materials and methods
2.1. Ethics statement
The present study was approved by the Safety Committee for
Gene Recombination Experiments of Yamagata University.
2.2. Cells and antibodies
COS-1 cells were maintained in Dulbecco's modiﬁed Eagle's
medium with 10% fetal bovine serum [4,5,10]. Monoclonal anti-
body against FLAG epitope (monoclonal anti-FLAG M2) was pur-
chased from SIGMA. Rabbit antiserum against the GST fusion
protein containing the CM2 protein (anti-GST/CM2 serum) was
prepared as described previously [3].
2.3. Construction of CM2 cytoplasmic tail mutants
A plasmid expressing FLAG-tagged wild-type CM2 (FLAG-CM2
1–115) was constructed as follows: cDNA from the M gene of in-
ﬂuenza C/Ann Arbor/1/50 covering positions 803–1150, which
encode residues 1–115 of CM2, was ﬁrst ampliﬁed using a sense
primer, þEcoRI-FLAG-M803 (5′-GACGAATTCACCATGGACTA-
CAAGGACGACGATGACAAGTGCAATCTAAAGACC-3′ [EcoRI site, un-
derlined; the nucleotides encoding the FLAG tag, bold, were fol-
lowed by the sequence corresponding to positions 803–817]), an
antisense primer, NotI-M1150 (5′-TATGCGGCCGCTTAAATTT-
CAAAAATACC-3′ [NotI site, underlined; the stop codon, bold, was
followed by the sequence corresponding to positions 1150–1133]),
and a PolI plasmid expressing segment 6 vRNA of inﬂuenza C/Ann
Arbor/1/50, pPolI/M, as a template [17,18]. The PCR products were
digested with EcoRI and NotI, and then cloned into the EcoRI and
NotI sites of the transient expression vector pME18S [23], desig-
nated pME18S/FLAG-CM2. A series of CM2 cytoplasmic tail dele-
tion mutants were constructed as follows. Brieﬂy, a plasmid ex-
pressing FLAG-tagged CM2 at residues 1–82 (FLAG-CM2 1–82) was
constructed by PCR mutagenesis using pME18S/FLAG-CM2 as a
template, þEcoRI-FLAG-M803 as a sense primer, and an antisense
primer, NotI-TTA-M1048 (5′-TATGCGGCCGCTTAATCTTTTTC-
CATCGAG-3′ [NotI site, underlined; the stop codon, bold, was fol-
lowed by the sequence corresponding to positions 1048–1033]).
The PCR products were digested with EcoRI and NotI, and then
cloned into the EcoRI and NotI sites of pME18S, designated
pME18S/FLAG-CM2 1–82. pME18S expressing FLAG-tagged CM2
deletion mutants composed of residues 1–72, 1–62, 1–52, and 1–47 were constructed as described above, except that the sequences
of the antisense primers were – NotI-TAA-M1018–1001 (5′-
TATGCGGCCGCTTAAATTGTGGTCTTTATATC-3′), – NotI-TAA-M988–
972 (5′-TATGCGGCCGCTTACTCCCATCTGCCGAGCA-3′), – NotI-TAA-
M958–944 (5′-TATGCGGCCGCTTAAAGTTCAATTATGAT-3′), and –
NotI-TAA-M943 (5′-TATGCGGCCGCTTATTTTACTAATAAATACAAC-
3′), respectively. For alanine-scanning analysis, a series of plasmids
expressing FLAG-tagged CM2 cytoplasmic tail mutants that con-
tained consecutive alanine substitutions were generated by in-
verse-PCR using a KOD-plus Mutagenesis Kit (TOYOBO). The pri-
mer sequences are available upon request. The sequences of all
constructs described above were veriﬁed by sequencing.
2.4. Immunoblotting of COS-1 cells expressing CM2 cytoplasmic tail
mutants
COS-1 cells were transfected with plasmids expressing CM2
cytoplasmic tail mutants as described previously [5]. The cells
were incubated at 37 °C, lysed at 48 h post-transfection, and re-
solved by SDS-PAGE on 17.5% gels containing 4 M urea under re-
ducing or non-reducing conditions, followed by immunoblotting
using monoclonal anti-FLAG M2 (SIGMA) as a primary antibody
and goat anti-mouse IgG (HþL)-HRP conjugate (BIORAD) as a
secondary antibody for deletion mutants, or anti-GST/CM2 serum
as a primary antibody and HRP-conjugated goat anti-rabbit Ig's
(BioSource International) as a secondary antibody for substitution
mutants, as described previously [15]. As an internal control, α-
tubulin was detected using mouse anti-α-tubulin (Santa Cruz
Biotechnology) as a primary antibody and goat anti-mouse IgG
(HþL)-HRP conjugate (BIORAD) as a secondary antibody. The
proteins were detected by an enhanced chemiluminescence
Western blotting analysis system (GE Healthcare, Piscataway, NJ)
according to the manufacturer's instructions. Band intensities
were measured using ImageJ 1.38 software (Wayne Rasband; Na-
tional Institute of Health [http://rsb.info.nih.gov/ij/]).
2.5. Indirect immunoﬂuorescence
Each plasmid expressing a CM2 cytoplasmic tail mutant was
transfected into COS-1 cells. The transfected cells were ﬁxed with
4% paraformaldehyde at 48 h post-transfection and stained with
monoclonal anti-FLAG M2 (SIGMA) as a primary antibody and
Alexa Fluor 488 goat anti-mouse IgG (HþL) (Molecular Probes) as
a secondary antibody. COS-1 cells transfected with pME18S alone
were immunostained as described above and shown as a control.3. Results and discussion
3.1. Expression of CM2 cytoplasmic tail deletion mutants
To investigate the effects of the cytoplasmic tail of CM2 on its
biochemical properties, we constructed a series of transient ex-
pression vectors encoding CM2 mutants with various deletions
from the C-terminus (Fig. 1A). COS-1 cells were transfected with
these vectors, lysed at 48 h post-transfection, and resolved by
electrophoresis under reducing conditions, followed by Western
blotting using an anti-FLAG monoclonal antibody. Representative
data for six independent experiments are shown in Fig. 1B. FLAG-
CM2 1–115 migrated electrophoretically as a nonglycosylated
form, CM20, and two glycosylated forms, CM2a and CM2b, con-
taining a high-mannose type and a complex type carbohydrate,
respectively. All CM2 deletion mutants migrated in accordance
with the expected molecular size. Although the expression levels
of FLAG-CM2 1–82 and 1–62 were the same as that of FLAG-CM2
1–115, the expression levels of FLAG-CM2 1–72 and 1–47 was
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Fig. 1. Construction of CM2 cytoplasmic tail deletion mutants and Western blot analysis. (A) FLAG-CM2 1–115 contains full-length CM2 amino acid residues 1–115. FLAG-
CM2 1–82, 1–72, 1–62, 1–52 and 1–47 contain 33-, 43-, 53-, 63-, and 68-amino-acid deletions from the C-terminus, respectively. Each plasmid expressing the FLAG-tagged
CM2 deletion mutants was transfected into COS-1 cells. pME18S alone was transfected as a negative control (lane vector). At 48 h post-transfection, the CM2 mutants
expressed in the cells were separated by electrophoresis under reducing (B) or non-reducing (C) conditions and detected by Western blotting using monoclonal anti-FLAG
M2. The tetramer (T) and dimer (D) of FLAG-CM2 1–115, as well as the T, D and monomer (M) of the CM2 cytoplasmic tail deletion mutants are indicated at the left and the
right of (C), respectively.
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CM2 1–47 being particularly low. The expression of FLAG-CM2 1–
52 was slightly smaller than that of the wild type. These results
suggest that amino acid residues in the regions including residues
73–82 and 48–62 may affect the level of CM2 expression. Next, the
cells expressing CM2 mutants were disrupted in the presence of
50 mM iodoacetamide, as described previously [7,10], and sepa-
rated by electrophoresis under non-reducing conditions, followed
by Western blotting (Fig. 1C). FLAG-CM2 1–115 was detected as
CM2a and CM2b, and most of the molecules migrated as dimers
and tetramers, as shown previously [7]. All CM2 cytoplasmic tail
deletion mutants, including FLAG-CM2 1–47, formed tetramers,
indicating that the cytoplasmic tail is not essential for the oligo-
merization of CM2. However, a considerable number of monomer
CM2 molecules were detected among the cytoplasmic deletion
mutants FLAG-CM2 1–82, 1–72, 1–62, and 1–52, suggesting that
the cytoplasmic tail modulates the efﬁciency of CM2 oligomer-
ization. A similar phenomenon; i.e., that mutations in the cyto-
plasmic domain affect oligomerization, has been demonstrated in
the vesicular stomatitis virus G protein, paramyxovirus HN pro-
tein, and paramyxovirus SV5 fusion (F) protein [24–26].
3.2. Cell surface expression of CM2 cytoplasmic tail deletion mutants
To examine the effect of the cytoplasmic tail on the cell surface
expression of CM2, COS-1 cells were transfected with plasmids
expressing the wild type or each of the CM2 cytoplasmic tail de-
letion mutants, FLAG-CM2 1–82, 1–72, 1–62, 1–52 and 1–47, ﬁxed
with 4% paraformaldehyde at 48 h post-transfection, and analyzed
by indirect immunoﬂuorescence with the anti-FLAG monoclonal
antibody (Fig. 2A). The cells expressing FLAG-CM2 1–82, 1–72, and
1–62 showed bright surface staining similar to that observed for
the wild type, suggesting that residues 63–115 are not essential for
the transportation of CM2 to the cell surface, and that the 16 cy-
toplasmic amino acids at residues 47–62 are sufﬁcient for the cell
surface expression of CM2. However, no signals were detected on
the surface of the cells expressing FLAG-CM2 1–52 and 1–47,
suggesting that the region from residues 53–62 may contain re-
sidues necessary for CM2 transportation to the cell surface. To
examine the intracellular expression of CM2 mutants in trans-
fected cells, the cells were permeabilized with Triton X-100 after
ﬁxation and analyzed by immunoﬂuorescence as described above
(Fig. 2B). There was no signiﬁcant difference in the intracellular
expression between FLAG-CM2 1–115 and the deletion mutants.To further examine which of the residues between 53 and 62
are required for cell surface expression, we constructed CM2 cy-
toplasmic tail deletion mutants FLAG-CM2 1–60, 1–57, and 1–54,
which included a 14-, 11-, and 8-aa cytoplasmic tail, respectively,
and analyzed their cell surface expression. Representative data for
ﬁve independent immunoﬂuorescence experiments are shown in
Fig. 2C. FLAG-CM2 1–60 showed the same level of cell surface
expression as did the wild-type FLAG-CM2 1–115. However, no cell
surface expression was detected for FLAG-CM2 1–57 or 1–54, al-
though aberrant granular signals were detected in some shrunken
cells. These data suggest that the C-terminal residues 61–115 are
not essential for the cell surface expression of CM2, and that a 14-
aa, but not an 11-aa, cytoplasmic tail is sufﬁcient for cell surface
expression. Immunoﬂuorescence after permeabilization with Tri-
ton X-100 showed that there was no signiﬁcant difference in the
intracellular expression levels between the wild-type FLAG-CM2
1–115 and the deletion mutants (Fig. 2D). It was also shown that
the wild type was detected in the periphery of the cytoplasm as
well as in the perinuclear region, whereas FLAG-CM2 1–47, 1–52
(Fig. 2B) and 1–54 (Fig. 2D) were all localized predominantly in the
perinuclear region, a ﬁnding which also suggests impaired in-
tracellular transport. The ﬁnding that the FLAG-CM2 1–47 and 1–
52 mutants were not detected at the cell surface (Fig. 2A) may be
partly explained by the low expression level of the protein as
Western blotting demonstrated that FLAG-CM2 1–47 and 1–52
have lower intracellular expression levels (Fig. 1B).
3.3. Properties of CM2 cytoplasmic tail mutants possessing alanine
substitutions
To further characterize the effects of the CM2 cytoplasmic tail
on its biochemical properties, we generated a series of CM2 mu-
tants by introducing consecutive alanine substitutions along the
CM2 cytoplasmic tail at residues 47–115 (Fig. 3). We ﬁrst analyzed
the expression levels of the alanine-substituted mutants by Wes-
tern blotting. The cells expressing CM2 mutants were lysed at 48 h
post-transfection, resolved by electrophoresis under reducing
(Fig. 4A) or non-reducing conditions (Fig. 4B), and analyzed by
Western blotting using anti-GST/CM2 serum. Representative data
for ﬁve independent experiments are shown in Fig. 4A. The ex-
pression levels of FLAG-CM2 Ala 47–48, 67–69, 73–75, 76–78, 79–
81, 82–84, 85–87, 88–90 and 113–115 were all reproducibly much
smaller than that of the wild type, suggesting that residues 47–48,
67–69, 73–90 and 113–115 are involved in the expression of CM2.
vector 1-115 1-82 1-72 vector 1-115 1-60
1-62 1-52 1-47 1-57 1-54
vector 1-115 1-82 1-72 vector 1-115 1-60
1-62 1-52 1-47 1-57 1-54
Fig. 2. Cell surface expression of CM2 cytoplasmic tail deletion mutants. Each plasmid expressing the FLAG-tagged CM2 deletion mutants (Fig. 1A), or pME18S alone as a
control (vector), was transfected into COS-1 cells. The cells were ﬁxed with 4% paraformaldehyde at 48 h post-transfection, subsequently untreated (A) or treated with 0.5%
Triton X-100 (B), and stained with monoclonal anti-FLAG M2 as a primary antibody and Alexa Fluor 488 goat anti-mouse IgG (HþL) as a secondary antibody. The cells
expressing CM2 cytoplasmic deletion mutants, FLAG-CM2 1–60, 1–57, and 1–54, composed of residues 1–60, 1–57 and 1–54, respectively, were ﬁxed, untreated (C) or treated
with Triton X-100 (D), and stained as described above.
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47–48, 52–54, 73–75 and 113–115, suggesting that residues 47–48,
52–54, 73–75 and 113–115 are involved in the conversion of CM2a
into CM2b, which is accompanied by the maturation of carbohy-
drates from a high-mannose type to a complex type [7]. Since it is
generally accepted that the maturation of N-linked carbohydrates
from a high-mannose type to a complex type is accomplished in
the Golgi apparatus [27], it is conceivable that residues 47–48, 52–
54, 73–75 and 113–115 may be involved in the transport of CM2
from the endoplasmic reticulum (ER) to the Golgi apparatus. These
data are in agreement with those from a previous report showing
that mutations in the cytoplasmic domain of the inﬂuenza A virus
hemagglutinin (HA), vesicular stomatitis virus G protein and
paramyxovirus hemagglutinin-neuraminidase (HN) protein affect
the intracellular transport of the proteins from the ER to the Golgi
apparatus [24,25,28]. By contrast, nonglycosylated CM2 was also
shown to be expressed at the cell surface [8,16]. Therefore, we
could not rule out the possibility that the CM2a or CM20 of these
CM2 cytoplasmic tail mutants may also be transported to the Golgi
apparatus and the cell surface as all substitution mutants were
expressed on the cell surface (Fig. 5). If this is the case, the in-
hibition of CM2a conversion to CM2b may be ascribed to an im-
pairment in the access of N-glycosylation-processing enzymes orFLAG niamodenarbmemsnarTniamodotcE
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Fig. 3. Construction of CM2 cytoplasmic tail mutants possessing alanine substitutions.
upper row. All constructs contain a FLAG tag at the N-terminus. Each of the mutants FLAG
indicated positions, except for FLAG-CM2 Ala 47–48 and 97–100, which contain two anoligosaccharide transferases to CM2 molecules, as it is possible
that mutations in the cytoplasmic tail cause conformational
changes to its ectodomain, which possesses the N-glycosylation
site. This idea appears to be supported by a previous report that
found that mutations in the cytoplasmic domain of the Lassa virus
glycoprotein caused conformational changes to its ectodomain,
thereby limiting the accessibility of the ectodomain to the protease
present in the ER [29]. To determine whether mutations in the
cytoplasmic tail of CM2 cause conformational changes to its ec-
todomain, we plan to generate monoclonal antibodies against the
CM2 ectodomain in the future.
Representative data for four independent Western blotting
experiments after SDS-PAGE under non-reducing conditions are
shown in Fig. 4B. All alanine-substituted mutants formed dimers
and tetramers, suggesting that the cytoplasmic tail is not essential
for CM2 oligomerization. This ﬁnding is consistent with the fact
that the CM2 cytoplasmic tail deletion mutant FLAG-CM2 1–47,
which lost virtually all of its cytoplasmic tail, also formed tetra-
mers (Fig. 1C). However, the efﬁciency of FLAG-CM2 Ala 73–75
tetramer formation was lower than that of the wild type and other
alanine-substituted mutants. These data raise the possibility that
residues 73–75 may regulate CM2 oligomerization efﬁciency.
We next analyzed the cell surface expression of the CM2liatcimsalpotyC
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The amino acid sequences of the wild-type CM2 cytoplasmic tail are shown in the
-CM2 Ala 47–48 to 113–115 contains three consecutive alanine substitutions at the
d four consecutive alanine substitutions, respectively.
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Fig. 4. Expression of CM2 cytoplasmic tail mutants possessing alanine substitu-
tions. Each plasmid expressing the FLAG-tagged CM2 substitution mutants (lanes
47–48 to 113–115), FLAG-CM2 1–115 (lane WT CM2), or pME18S alone as a control
(lane vector) was transfected into COS-1 cells. At 48 h post-transfection, the CM2
mutants expressed in the cells were separated by electrophoresis under reducing
(A) or non-reducing (B) conditions and detected by Western blotting using anti-
GST/CM2 serum. The lowest panel shows α-tubulin as an internal control.
vector WT CM2 47-48
55-57 58-60 61-63
70-72 73-75 76-78
85-87 88-90 91-93
101-103 104-106 107-10
Fig. 5. Cell surface expression of CM2 cytoplasmic tail mutants containing alanine substit
to 113–115), FLAG-CM2 1–115 (WT CM2), or pME18S alone as a control (vector) was trans
transfection and analyzed by immunoﬂuorescence as described in Fig. 2A.type, suggesting that no speciﬁc cytoplasmic residues are required
for CM2 transportation to the cell surface. This is consistent with
our previous reports that Ala substitutions at residue 65 (acylation
site) as well as residues 78, 103 and 108 (candidate sites for
phosphorylation) did not affect the cell surface expression of CM2
[9,18].
To determine whether the above data showing that consecutive
alanine substitutions at residues 47–48, 67–69, 73–90 and 113–115
reduced the amount of expressed CM2 mutants could be ascribed
to their instability, pulse-chase experiments were performed with
COS-1 cells transfected with plasmids expressing CM2 alanine-
substituted mutants, FLAG-CM2 Ala 47–48, 67–69, 73–75, 79–81,
82–84, 85–87 and 113–115, as described previously [7]. The cells
were pulse-labeled with [35S]methionine for 30 min at 48 h post-
transfection. Either immediately after a pulse or a subsequent
chase of 2 h, the cells were disrupted in RIPA buffer and im-
munoprecipitated with anti-GST/CM2 serum. The im-
munoprecipitates were analyzed by SDS-PAGE on 17.5% gels con-
taining 4 M urea under reducing conditions and processed for
ﬂuorography (data not shown). Densitometric analysis of the re-
presentative data for two independent experiments showed that
the ratios of the total amount of CM2 proteins after a 2-h chase to
that after a 30-min pulse in the cells expressing wild-type CM2,
FLAG-CM2 Ala 47–48, 67–69, 73–75, 79–81, 82–84, 85–87, and
113–115 were 0.87, 0.46, 0.53, 0.40, 0.74, 0.74, 0.63, and 0.92, re-
spectively. The total amount of CM2 proteins was reduced during
the chase in the cells expressing wild-type CM2; however, the
degree of reduction was more prominent in the cells expressing
FLAG-CM2 Ala 47–48, 67–69, 73–75, 79–81, 82–84 and 85–87,
suggesting that residues 47–48, 67–69, 73–75 and 79–87 may play
a role in CM2 stability and, thus, are involved in its expression
level. By contrast, FLAG-CM2 Ala 113–115 showed a level of sta-
bility similar to that of the wild-type CM2. Therefore, the me-
chanism underlying the low level of FLAG-CM2 Ala 113–115 ex-
pression remains unclear. Furthermore, the data demonstrated
that the tetramerization of FLAG-CM2 Ala 73–75 was impaired
(Fig. 4B), indicating that FLAG-CM2 Ala 73–75 may take an aber-
rant conformation, thereby causing it to become unstable. There-
fore, it is possible that 73-MPE-75 plays an important role in49-51 52-54
64-66 67-69
79-81 82-84
94-96 97-100
9 110-112 113-115
utions. Each plasmid expressing the FLAG-tagged CM2 substitution mutants (47–48
fected into COS-1 cells. The cells were ﬁxed with 4% paraformaldehyde at 48 h post-
Y. Shimotai et al. / Biochemistry and Biophysics Reports 3 (2015) 1–66ensuring proper conformation, providing CM2 with both stability
and suitable access to enzymes involved in N-glycosylation during
its intracellular transport. However, we could not rule out the
possibility that the reason why the tetramerization of FLAG-CM2
Ala 73–75 was impaired (Fig. 4B) was partly that we changed a
proline residue, which tends to introduce speciﬁc conformational
constraints, and a charged glutamic acid residue, which is often
involved in salt-bridges. By contrast, Western blot analysis of in-
ﬂuenza A virus M2 protein demonstrated that triple-scanning
alanine mutations in the cytoplasmic tail at residues 46–69 did not
alter the oligomerization potential of M2 when alanine substitu-
tions were introduced at Glu56, Pro63, Glu66, and Pro69 [30].
The results of this study suggest that certain amino acid se-
quences or the length of the CM2 cytoplasmic tail are involved in
the proper conformational maturation, stability, expression level
and intracellular transport of CM2. However, it remains to be de-
termined whether these CM2 cytoplasmic tail mutations affect
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